GRV STRATEGIES LLC

Lobbying for ELI LILLY AND COMPANY · Biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Indiana · House · Senate · $60,000.00 income · posted Oct 9, 2025

Lobbying activity 2

Health Issues

Issues related to healthcare

Trade (domestic/foreign)

Issues related to trade

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem